Does diurnal variation affect the first trimester fetal aneuploidy screening test biochemical parameters of fetuses with normal nuchal translucency?

References

• Wright D, Spencer K, Nix B. First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study. Prenat Diagn 2007;27:1118–22
   PubMed Web of Science ®Google Scholar
• Jaques AM, Halliday JL, Francis I, et al. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18. BJOG 2007;114:812–18
   PubMed Web of Science ®Google Scholar
• Liao AW, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001;16:1501–4
   PubMed Web of Science ®Google Scholar
• Spencer K. The influence of smoking on maternal serum PAPPA and free beta hCG levels in the first trimester of pregnancy. Prenat Diagn 1999;19:1065–6
   PubMed Web of Science ®Google Scholar
• Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 2000;20:491–4
   PubMed Web of Science ®Google Scholar
• Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2003;23:851–5
   PubMed Web of Science ®Google Scholar
• Spencer K, Crossley JA, Aitken DA, et al. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient specific risks and the detection rates for Down’s syndrome. Ann Clin Biochem 2003;40:219–31
   PubMed Web of Science ®Google Scholar
• Kagan OK, Wright D, Valencia C, et al. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free b-hCG and pregnancy-associated plasma protein-A. Human Reprod 2008;23:1968–75
   PubMed Web of Science ®Google Scholar
• Barrett SL, Bower C, Hadlow NC. Use of the combined first trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 2008;28:28–35
   PubMed Web of Science ®Google Scholar
• Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762–7
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008;28:7–10
   PubMed Web of Science ®Google Scholar
• Yaron Y, Heifetz S, Ochshorn Y, et al. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002;22:778–82
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Spencer CE, Achillea N. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2010;30:937–40
   PubMed Web of Science ®Google Scholar
• Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 2010;30:235–40
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Stamatopoulou A, Spencer K. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency. Prenat Diagn 2009;29:505–7
   PubMed Web of Science ®Google Scholar
• Karsli MF, Baser E, Seckin KD, et al. The impact of inherited thrombophilia on first trimester combined aneuploidy screening test parameters. J Matern Fetal Neonatal Med 2014;27:346–9
   PubMed Web of Science ®Google Scholar
• Karsli MF, Gultekin IB, Cakmak B, et al. Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome? Prenat Diagn 2014;34:1073–6
   PubMed Web of Science ®Google Scholar
• Hadlow NC, Brown S, Wardrop R, Henley D. The effects of season, daylight saving and time of sunrise on serum cortisol in a large population. Chronobiol Int 2014;31:243–51
   PubMed Web of Science ®Google Scholar
• Apter D, Butzow TL, Laughlin GA, Yen SS. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. J Clin Endocrinol Metab 1993;76:940–9
   PubMed Web of Science ®Google Scholar
• Bischof P, Duberg S, Schindler AM, et al. Endometrial and plasma concentrations of pregnancy-associated plasma protein-A. Br J Obstet Gynaecol 1982;89:701–3
   PubMedGoogle Scholar
• Westergaard JG, Teisner B, Grudzinskas JG. Serum PAPP-A in normal pregnancy: relationship to fetal and maternal characteristics. Arch Gynecol 1983;233:211–15
   PubMedGoogle Scholar
• Houghton, DJ, Newnham JP, Litau MJ, Chard T. Short term variation in the level of alpha-fetoprotein in maternal serum. Br J Obstet Gynaecol 1983;90:235–7
   PubMedGoogle Scholar
• Pekonen F, Alfthan, H, Stenman U, Ylikorkala O. Human chorionic gonadotropin (hCG) and thyroid function in early human pregnancy: circadian variance and evidence for intrinsic thyrotropic activity of hCG. J Clin Endocrinol Metab 1988;66:853–6
   PubMed Web of Science ®Google Scholar
• Goebel R, Kuss E. Circadian rhythm of serum unconjugated estriol in late pregnancy. J Clin Endocrinol Metab 1974;39:969–72
   PubMed Web of Science ®Google Scholar
• Selinger M, Levitz M. Diurnal variation of total plasma estriol levels in late pregnancy. J Clin Endocrinol Metab 1969;26:995–7
   Google Scholar
• Townsley JD, Dubin NH, Grannis GF, et al. Circadian rhythms of serum and urinary estrogens in pregnancy. J Clin Endocrinol Metab 1973;36:289–95
   PubMed Web of Science ®Google Scholar
• Katagiri H, Distler W, Freeman RF, Goebelsmann U. Estriol in pregnancy. Normal concentrations, diurnal andlor episodic variations, and day to day changes of unconjugated estriol and total estriol in late pregnancy plasma. Am J Obstet Gynecol 1975;124:272–80
   Web of Science ®Google Scholar
• Levitz M, Slyper AJ, Selinger M. On the lack of periodicity in plasma estriol in human pregnancy. J Clin Endocrinol Metab 1973;38:698–700
   Web of Science ®Google Scholar
• Bashore RA, Westlake JR. Plasma unconjugated estriol values in high-risk pregnancy. Am J Obstet Gynecol 1977;128:371–80
   PubMed Web of Science ®Google Scholar
• Rose NC, Canickt JA, Knights GJ, et al. Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient’s risk for fetal down syndrome? Prenat Diagn 1994;14:947–51
   PubMed Web of Science ®Google Scholar
• Rotmensch S, Celentano C, Elliger N, et al. Diurnal variation of human chorionic gonadotropin b-core fragment concentrations in urine during second trimester of pregnancy. Clin Chem 2001;47:1715–17
   PubMed Web of Science ®Google Scholar
• Neven P, Iles RK, Carter PG, et al. Diurnal variation of urinary “hCG beta subunit core fragment” production evaluated in patients with gynecological neoplasms. Clin Chem 1994;40:484–5
   PubMed Web of Science ®Google Scholar
• Scott F, Coates A, McLennan A. Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels. Aust NZ J Obstet Gynaecol 2009;49:258–62
   PubMed Web of Science ®Google Scholar
• Barrett SL, Bower C, Hadlow NC. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 2008;28:28–35
   PubMed Web of Science ®Google Scholar
• Spencer CA, Allen VM, Flowerdew G, et al. Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes. Prenat Diagn 2008;28:1029–36
   PubMed Web of Science ®Google Scholar